1724918

Zolpidem Related Compound A

United States Pharmacopeia (USP) Reference Standard

• Synonym(s): N,N-Dimethyl-2-[7-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide
• Empirical Formula (Hill Notation): C₁₉H₂₁N₃O
• Molecular Weight: 307.39
• MDL number: MFCD23136997
• UNSPSC Code: 41116107
• NACRES: NA.24

Properties

• API family: zolpidem
• manufacturer/tradename: USP
• application(s): pharmaceutical (small molecule)
• SMILES string: CC1=CC=C(C=C1)C2=C(CC(N(C)C)=O)N3C=CC(C)=CC3=N2
• InChI: 1S/C19H21N3O/c1-13-5-7-15(8-6-13)19-16(12-18(23)21(3)4)22-10-9-14(2)11-17(22)20-19/h5-11H,12H2,1-4H3
• InChI key: CZVNHSKGTUTQHR-UHFFFAOYSA-N

Description

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Zolpidem Related Compound A USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:

• Zolpidem Tartrate
• Zolpidem Tartrate Extended-Release Tablets
• Zolpidem Tartrate Tablets

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Other Notes

USP issued SDS can be found here.

Sales restrictions may apply.

Safety Information

• pictograms: GHS07,GHS09
• signalword: Warning
• hcodes: H302,H336,H411
• pcodes: P261 - P264 - P271 - P273 - P301 + P312 - P304 + P340 + P312
• Hazard Classifications: Acute Tox. 4 Oral - Aquatic Chronic 2 - STOT SE 3
• target_organs: Central nervous system
• Storage Class: 11 - Combustible Solids
• wgk_germany: WGK 2
• flash_point_f: Not applicable
• flash_point_c: Not applicable